Atlas Trials

Tacrolimus as Secondary Intervention vs. Continuation of Cyclosporine in Renal Transplant Patients With Chronic Renal Allograft Failure (CRAF)

Clinical trial NCT00637143 · COMPLETED

Trial details

NCT number
NCT00637143
Sponsor
Astellas Pharma Inc
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Renal TransplantationChronic Renal Allograft Failure
Start date
1999-04-01
Primary completion
2006-02-01
Enrollment
107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.